secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0000898432-24-000143
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellevue Life Sciences receives Nasdaq deficiency notice for minimum public holders
--------------------------------------------------------------------------------

- Received Nasdaq notice on Feb 15, 2024, for failing the minimum 300 public holders requirement (Rule 5550(a)(3)).
- Company has 45 calendar days, until April 1, 2024, to submit a plan to regain compliance.
- If plan is accepted, Nasdaq may grant an extension of up to 180 days from the notice date.
- Notice has no immediate effect on the listing of the company's securities on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000089843224000143/0000898432-24-000143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000089843224000143/form8k.htm
  HTML page:      https://secwatch.observer/filing/0000898432-24-000143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer